GENE ONLINE|News &
Opinion
Blog

LATEST
Sanofi Announces First Acquisition Deal of 2024 to Strengthen Rare Disease Portfolio at $2.2 Billion
2024-01-24
New Technology and Nomenclature to Lead the Transformation of Fatty Liver Disease Diagnosis
2024-01-24
Biotech Showcase 2024: A Wave of Innovation Washes Over Healthcare’s Future (Oncology Sector)
2024-01-24
FDA’s Boxed Warning Highlights Low Calcium Dangers with Prolia
2024-01-22
Arab Health 2024 Sells Out as International Exhibitors Hit Record Levels
2024-01-19Partner
AstraZeneca Invests $26.5 Million in New Production Line for Diabetes Drug in China
2024-01-19
Parexel and Japanese Foundation for Cancer Research Collaborate to Boost Oncology Clinical Trials in Japan
2024-01-18
Groundbreaking CRISPR/Cas9-based Genome Editing Therapy Secured the Second FDA Approval
2024-01-18
Biotech and Pharma IPOs Surge with Innovative Therapies in the Beginning of 2024: From Kymera Therapeutics to Kyverna Therapeutics Lead the Way
2024-01-18
The Gates Foundation Boosts Global Health Innovations with Record $8.6 Billion Budget
2024-01-18
Bora Pharmaceutical Makes First U.S. Acquisition to Buy Upsher-Smith for $210 Million
2024-01-17
Semaglutide-Based Medications, Ozempic and Wegovy, Show Lower Suicidal Ideation Risk
2024-01-17
Lunit AI Solutions to Power Samsung’s X-ray Devices for Advanced Chest Screening
2024-01-16
Neurolief’s Neuromodulation Device Receives Japanese Approval for At-Home Migraine Treatment
2024-01-16
GeneOnline’s Pick – Top 10 Global Industry News Stories in 2023 (Part 2)
2024-01-15
1 5 6 7 8 9 218
EVENT
Scroll to Top